I don't think so.
This rego trial doesn't even start until 2024 and then surely we would be several months into 2024 from actual revenue + with a CR of what 100 Mill, (Assuming it done a discount - most likely), I expect we will be in the doldrums (SP wise) for the next 6-9 months. Plenty of time to continue to short and close out.
Ann: Imugene Licenses Allogeneic CD19 CAR T Cell Therapy, page-40
-
- There are more pages in this discussion • 467 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $433.6M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 267 | 6.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 26990 | 1 |
View Market Depth
| Last trade - 09.50am 15/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
Day chart unavailable